The prevalence and clinical implication of rare germline deleterious alterations in Chinese patients with prostate cancer: A real‐world multicenter study
Xiaochen Fei(Renji Hospital), Wei Xue(Shanghai Jiao Tong University), Jiahua Pan(University of Science and Technology of China), Wanbing Zhao(Kingmed Diagnostics), Fangqin Wang(Kingmed Diagnostics), Xinxing Du(Shanghai Jiao Tong University), Liancheng Fan(Shanghai Jiao Tong University), Tongtong Liu(Heilongjiang University of Chinese Medicine), Yanqing Wang(First Affiliated Hospital of Xiamen University), Yiming Gong(Chongqing University), Yinjie Zhu(Shanghai Jiao Tong University), Yining Yang(Kingmed Diagnostics), Wei Chen(Wenzhou Medical University), Wei Chen(Sun Yat-sen University), Baijun Dong(Renji Hospital)
Cited by 4
Related Papers
Single-cell analysis supports a luminal-neuroendocrine transdifferentiation in human prostate cancer
|Communications Biology|2020|222
Metabolic Control by Heat Stress Determining Cell Fate to Ferroptosis for Effective Cancer Therapy
|ACS Nano|2021|169
Numb/Parkin-directed mitochondrial fitness governs cancer cell fate via metabolic regulation of histone lactylation
|Cell Reports|2023|161
Glucose limitation activates AMPK coupled SENP1-Sirt3 signalling in mitochondria for T cell memory development
|Nature Communications|2021|147
DNA-framework-based multidimensional molecular classifiers for cancer diagnosis
|Nature Nanotechnology|2023|146